<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
    <channel>
        <atom:link href="https://www.health.harvard.edu/authors/holly-strawbridge/feed/rss" rel="self" type="application/rss+xml" />
        <title><![CDATA[Harvard Health Posts by Holly Strawbridge Feed]]></title>
        <link><![CDATA[https://www.health.harvard.edu/authors/holly-strawbridge]]></link>
        <image>
            <url>https://www.health.harvard.edu/img/logos/hhp-logo-mark-lg.jpg</url>
            <height>173</height>
            <width>144</width>
            <title><![CDATA[Harvard Health Posts by Holly Strawbridge Feed]]></title>
            <link><![CDATA[https://www.health.harvard.edu/authors/holly-strawbridge]]></link>
        </image>
        <description><![CDATA[Harvard Health Blog: You'll find posts from Harvard Medical School physicians and our editors on a variety of health news and issues.]]></description>
        <language>en-US</language>
        <pubDate>Wed, 29 Jan 2020 00:00:00 -0500</pubDate>

                    <item>
                <title><![CDATA[Going gluten-free just because? Here&rsquo;s what you need to know]]></title>
                <link>https://www.health.harvard.edu/blog/going-gluten-free-just-because-heres-what-you-need-to-know-201302205916</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[Holly Strawbridge]]></author>
                
                <guid isPermaLink="true">https://www.health.harvard.edu/blog/going-gluten-free-just-because-heres-what-you-need-to-know-201302205916</guid>
                <pubDate>Wed, 29 Jan 2020 00:00:00 -0500</pubDate>
                <source url="https://www.health.harvard.edu/authors/holly-strawbridge/feed/rss"><![CDATA[Harvard Health Posts by Holly Strawbridge Feed]]></source>
                            </item>
                    <item>
                <title><![CDATA[Drug hazard information fades when prescription meds switch to OTC]]></title>
                <link>https://www.health.harvard.edu/blog/drug-hazard-information-fades-when-prescription-meds-switch-to-otc-201209195324</link>
                <description><![CDATA[It&#8217;s natural to assume that all OTC drugs are safe for just about everyone. But that&#8217;s a mistake. A recent report in JAMA by Harvard-affiliated physicians found that when a prescription drug moves to OTC status, balanced advertising tends to fly out the window. Of the four drugs randomly selected for the study—omeprazole (Prilosec, Nexium), orlistat (Alli), loratadine (Claritin), and cetirizine (Zyrtec), only Alli mentioned any potential harmful effects at all. One reason for this is that the Food and Drug Administration (FDA), which oversees the advertising of prescription drugs, insists that every side effect and interaction found in clinical trials of the medication be included in every ad. But OTC advertising is overseen by the Federal Trade Commission, which requires only that ads meet a &#8220;reasonable consumer&#8221; standard of truthfulness. Does this mean drugs should not be sold OTC? Of course not. But you can avoid potential pitfalls by asking a pharmacist whether the drug is okay for you to take.]]></description>
                <author><![CDATA[Holly Strawbridge]]></author>
                
                <guid isPermaLink="true">https://www.health.harvard.edu/blog/drug-hazard-information-fades-when-prescription-meds-switch-to-otc-201209195324</guid>
                <pubDate>Wed, 19 Sep 2012 18:09:06 -0400</pubDate>
                <source url="https://www.health.harvard.edu/authors/holly-strawbridge/feed/rss"><![CDATA[Harvard Health Posts by Holly Strawbridge Feed]]></source>
                            </item>
                    <item>
                <title><![CDATA[Artificial sweeteners: sugar-free, but at what cost?]]></title>
                <link>https://www.health.harvard.edu/blog/artificial-sweeteners-sugar-free-but-at-what-cost-201207165030</link>
                <description><![CDATA[]]></description>
                <author><![CDATA[Holly Strawbridge]]></author>
                
                <guid isPermaLink="true">https://www.health.harvard.edu/blog/artificial-sweeteners-sugar-free-but-at-what-cost-201207165030</guid>
                <pubDate>Wed, 29 Jan 2020 00:00:00 -0500</pubDate>
                <source url="https://www.health.harvard.edu/authors/holly-strawbridge/feed/rss"><![CDATA[Harvard Health Posts by Holly Strawbridge Feed]]></source>
                                    <category>Healthy aging and longevity</category>
                            </item>
                    <item>
                <title><![CDATA[Heart attack can trigger PTSD]]></title>
                <link>https://www.health.harvard.edu/blog/heart-attack-can-trigger-ptsd-201206254939</link>
                <description><![CDATA[We usually think of post-traumatic stress disorder (PTSD) as an aftermath of military combat or terrible trauma. It can also strike heart attack survivors. By the latest account, 1 in 8 people who live through a heart attack experiences a PTSD-like reaction that might be called post-traumatic stress disorder (PTSD). They experience the same key symptoms: flashbacks that occur as nightmares or intrusive thoughts. They try to avoid being reminded of the event and become hypervigilant worrying that it will happen again. As treatments for heart attack continue to improve, 1.4 million people a year are now surviving the event long enough to be discharged home. If the study is correct, 168,000 of them will be diagnosed with PTSD every year. It&#8217;s a grim reminder that as we get better at fixing the body, we must recognize the need to treat the mind.]]></description>
                <author><![CDATA[Holly Strawbridge]]></author>
                
                <guid isPermaLink="true">https://www.health.harvard.edu/blog/heart-attack-can-trigger-ptsd-201206254939</guid>
                <pubDate>Mon, 25 Jun 2012 18:06:00 -0400</pubDate>
                <source url="https://www.health.harvard.edu/authors/holly-strawbridge/feed/rss"><![CDATA[Harvard Health Posts by Holly Strawbridge Feed]]></source>
                                    <category>Heart Health</category>
                                    <category>Mental Health</category>
                            </item>
                    <item>
                <title><![CDATA[Some antibiotic, antifungal drugs don&#8217;t mix with warfarin]]></title>
                <link>https://www.health.harvard.edu/blog/some-antibiotic-antifungal-drugs-dont-mix-with-warfarin-201206074857</link>
                <description><![CDATA[Millions of people depend on the blood thinner warfarin to prevent clots from forming in their blood. It&#8217;s an important drug, but tricky to use. One problem with warfarin (Coumadin, Jantoven, generic) is that it interacts in potentially harmful ways with other medications. Two problematic types are antibiotics and antifungal agents. As we write in the June issue of the Harvard Heart Letter, this isn&#8217;t just a problem with pills, but can also happen with ointments, creams, and suppositories. Adding an antibiotic such as cotrimoxazole, cephalexin, or penicillin, or an antifungal medicine such as itraconazole or ketoconazole on top of warfarin can heighten warfarin&#8217;s blood-thinning ability. This raises the risk of internal bleeding or sustained bleeding after an injury.]]></description>
                <author><![CDATA[Holly Strawbridge]]></author>
                
                <guid isPermaLink="true">https://www.health.harvard.edu/blog/some-antibiotic-antifungal-drugs-dont-mix-with-warfarin-201206074857</guid>
                <pubDate>Thu, 07 Jun 2012 14:08:27 -0400</pubDate>
                <source url="https://www.health.harvard.edu/authors/holly-strawbridge/feed/rss"><![CDATA[Harvard Health Posts by Holly Strawbridge Feed]]></source>
                                    <category>Heart Health</category>
                            </item>
                    <item>
                <title><![CDATA[Link between calcium supplements and heart disease raises the question: Take them or toss them?]]></title>
                <link>https://www.health.harvard.edu/blog/link-between-calcium-supplements-and-heart-disease-raises-the-question-take-them-or-toss-them-201205304813</link>
                <description><![CDATA[Calcium supplements are being called on the carpet after new research showed they significantly increased risk of heart attack among women getting extra calcium from pills, but not among those who got their calcium from food. What&#8217;s the connection? Over time, calcium can accumulate in arteries. It also builds up in plaque, the cholesterol-filled pockets that can cause angina or a heart attack. Three Harvard professors say the new study doesn&#8217;t prove that calcium supplements cause heart disease, but advocate that it&#8217;s almost always best to get vitamins and minerals from food, not pills.]]></description>
                <author><![CDATA[Holly Strawbridge]]></author>
                
                <guid isPermaLink="true">https://www.health.harvard.edu/blog/link-between-calcium-supplements-and-heart-disease-raises-the-question-take-them-or-toss-them-201205304813</guid>
                <pubDate>Wed, 30 May 2012 16:43:50 -0400</pubDate>
                <source url="https://www.health.harvard.edu/authors/holly-strawbridge/feed/rss"><![CDATA[Harvard Health Posts by Holly Strawbridge Feed]]></source>
                                    <category>Heart Health</category>
                                    <category>Osteoporosis</category>
                            </item>
                    <item>
                <title><![CDATA[Wallets rejoice as Plavix goes generic]]></title>
                <link>https://www.health.harvard.edu/blog/wallets-rejoice-as-plavix-goes-generic-201205214727</link>
                <description><![CDATA[Millions of people with heart disease who take the blood thinner clopidogrel (Plavix) can now look forward to having fatter wallets. Plavix lost its patent protection this month, and on May 17 the Food and Drug Administration gave several companies the okay to sell its generic form. Clopidogrel users can now buy brand-name Plavix for a premium price, or equally effective generic clopidogrel in a 75-mg dose at a much lower cost. The change may also save lives. &#8220;We have seen more than a few patients have heart attacks because they had stopped taking clopidogrel due to the expense,&#8221; said Dr. Thomas Lee, professor of medicine at Harvard Medical School and Co-Editor in Chief of the Harvard Heart Letter. &#8220;I think the lower price is going to save some lives.&#8221; Before a company can sell a generic version of a drug, it must prove to the FDA that the drug is as effective and safe as the original.]]></description>
                <author><![CDATA[Holly Strawbridge]]></author>
                
                <guid isPermaLink="true">https://www.health.harvard.edu/blog/wallets-rejoice-as-plavix-goes-generic-201205214727</guid>
                <pubDate>Mon, 21 May 2012 14:06:23 -0400</pubDate>
                <source url="https://www.health.harvard.edu/authors/holly-strawbridge/feed/rss"><![CDATA[Harvard Health Posts by Holly Strawbridge Feed]]></source>
                                    <category>Heart Health</category>
                            </item>
            </channel>
</rss>
